Results 271 to 280 of about 26,893,016 (421)

Cell cycle, cell division, cell death

open access: yesMolecular Biology of the Cell, 2019
Jan M. Skotheim, Amy Shaub Maddox
openaire   +2 more sources

Cystatin A promotes the antitumor activity of T helper type 1 cells and dendritic cells in murine models of pancreatic cancer

open access: yesMolecular Oncology, EarlyView.
Pancreatic ductal adenocarcinoma (PDAC) is a disease with very poor prognosis due to therapeutic limitations. We investigated the antitumor effects of cystatin A (CSTA) in PDAC murine models. We are first to confirm that CSTA enhances T helper type 1‐mediated antitumor effects through promotion of dendritic cells and M1 macrophage activity. CSTA can be
Alessandro Nasti   +8 more
wiley   +1 more source

Editorial: Cell Organelle Exploitation by Viruses During Infection

open access: yesFrontiers in Microbiology, 2021
Parikshit Bagchi   +2 more
doaj   +1 more source

Reduced occludin expression is related to unfavorable tumor phenotype and poor prognosis in many different tumor types: A tissue microarray study on 16,870 tumors. [PDF]

open access: yesPLoS One
Büyücek S   +30 more
europepmc   +1 more source

Matrix Elasticity Directs Stem Cell Lineage Specification

open access: yesCell, 2006
A. Engler   +5 more
semanticscholar   +1 more source

Cell‐free DNA aneuploidy score as a dynamic early response marker in prostate cancer

open access: yesMolecular Oncology, EarlyView.
mFast‐SeqS‐based genome‐wide aneuploidy scores are concordant with aneuploidy scores obtained by whole genome sequencing from tumor tissue and can predict response to ARSI treatment at baseline and, at an early time point, to ARSI and taxanes. This assay can be easily performed at low cost and requires little input of cfDNA. Cell‐free circulating tumor
Khrystany T. Isebia   +17 more
wiley   +1 more source

Home - About - Disclaimer - Privacy